PROTECT-CHILD Pediatric Transplant Data Implementation Guide, published by Protect Child. This guide is not an authorized publication; it is the continuous build for version 0.1.0-ci-build built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/protect-child/ and changes regularly. See the Directory of published versions
: Example Immunosuppressant — Basiliximab - TTL Representation
Raw ttl | Download
@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
# - resource -------------------------------------------------------------------
<http://hl7.org/fhir/Medication/ImmunosuppressantBasiliximab1> a fhir:Medication ;
fhir:nodeRole fhir:treeRoot ;
fhir:Resource.id [ fhir:value "ImmunosuppressantBasiliximab1"] ;
fhir:Resource.meta [
fhir:Meta.profile [
fhir:value "https://hl7.eu/fhir/ig/hl7.eu.fhir.protect-child/StructureDefinition/immunosuppressant" ;
fhir:index 0 ;
fhir:link <https://hl7.eu/fhir/ig/hl7.eu.fhir.protect-child/StructureDefinition/immunosuppressant>
]
] ;
fhir:DomainResource.text [
fhir:Narrative.status [ fhir:value "generated" ] ;
fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: Medication ImmunosuppressantBasiliximab1</b></p><a name=\"ImmunosuppressantBasiliximab1\"> </a><a name=\"hcImmunosuppressantBasiliximab1\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-immunosuppressant.html\">Immunosuppressant</a></p></div><p><b>identifier</b>: <a href=\"NamingSystem-NsProtectChildId.html\" title=\"Single identifier namespace for PROTECT-CHILD record business identifiers (patient, donor, visit, transplant, and all per-visit clinical/lab/medication/specimen/event records). The resource type distinguishes the kind of record. Identifiers follow one convention: TOKEN-CENTRE-SEQUENCE, for example REC-1-0001 (patient, centre 1, sequence 1) or LBR-1-0006 (lab result); study-wide catalogue entries such as lab tests are not centre-qualified and use TOKEN-SEQUENCE, for example LBT-0001. Identifiers carry no clinical meaning.\">ProtectChildId</a>/IMM-0003</p><p><b>code</b>: <span title=\"Codes:{https://hl7.eu/fhir/ig/hl7.eu.fhir.protect-child/CodeSystem/immunosuppressant-drug-type-cs 19038440}\">Basiliximab</span></p><p><b>status</b>: Active</p></div>"
] ;
fhir:Medication.identifier [
fhir:index 0 ;
fhir:Identifier.system [ fhir:value "https://hl7.eu/fhir/ig/hl7.eu.fhir.protect-child/NamingSystem/protect-child-id" ] ;
fhir:Identifier.value [ fhir:value "IMM-0003" ]
] ;
fhir:Medication.code [
fhir:CodeableConcept.coding [
fhir:index 0 ;
fhir:Coding.system [ fhir:value "https://hl7.eu/fhir/ig/hl7.eu.fhir.protect-child/CodeSystem/immunosuppressant-drug-type-cs" ] ;
fhir:Coding.code [ fhir:value "19038440" ] ;
fhir:Coding.display [ fhir:value "Basiliximab" ]
]
] ;
fhir:Medication.status [ fhir:value "active"] .
# - ontology header ------------------------------------------------------------
<http://hl7.org/fhir/Medication/ImmunosuppressantBasiliximab1.ttl> a owl:Ontology ;
owl:imports fhir:fhir.ttl ;
owl:versionIRI <http://build.fhir.org/Medication/ImmunosuppressantBasiliximab1.ttl> .